Rocket Pharmaceuticals Inc buy melinda
Start price
03.01.17
/
50%
€6.22
Target price
29.03.17
€18.04
Performance (%)
11.59%
End price
29.03.17
€6.95
Summary
This prediction ended on 29.03.17 with a price of €6.95. The prediction had a final performance of 11.59%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Rocket Pharmaceuticals Inc | -0.523% | -0.523% | 35.591% | -41.601% |
| iShares Core DAX® | 0,22 % | 1,49 % | 3,58 % | 50,28 % |
| iShares Nasdaq 100 | 6,05 % | 16,19 % | 39,14 % | 107,46 % |
| iShares Nikkei 225® | 5,72 % | 11,69 % | 50,96 % | 76,35 % |
| iShares S&P 500 | 2,17 % | 8,06 % | 25,62 % | 72,62 % |
Comments by melinda for this prediction
In the thread Rocket Pharmaceuticals Inc diskutieren
folgen
$ ITEK Herabstufung von Übergewicht bei Piper zu neutral. PT $ 3 $ 24
(Vom Mitglied beendet)
Stopped prediction by melinda for Rocket Pharmaceuticals Inc
Rocket Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€9.02
27.10.17
27.10.17
€18.04
29.12.17
29.12.17
8.40%
29.12.17
29.12.17
Rocket Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€10.00
27.10.17
27.10.17
€20.00
29.12.17
29.12.17
8.40%
29.12.17
29.12.17
Rocket Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€7.22
25.04.17
25.04.17
€7.58
26.04.17
26.04.17
5.00%
26.04.17
26.04.17